Iacopo Muraca

Iacopo Muraca

Auto-generated profile, based on publicly available information

Iacopo Muraca

Cardiovascular Department Careggi University Hospital Florence Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2020 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
IMIacopo Muraca
Iacopo Muraca
MPMatteo Pennesi
Matteo Pennesi
NCNazario Carrabba
Nazario Carrabba
FSFernando Scudiero
Fernando Scudiero
AMAngela Migliorini
Angela Migliorini
RVRenato Valenti
Renato Valenti
Background: Currently, the use of advanced ventricular support systems during percutaneous mitral valve repair (PMVR) procedures is confined to very few selected cases in emergency or bailout situations. No cases are reported of planned use of ventricular support devices in the subgroup of high-risk patients undergoing PMVR. Case summary: We report two cases of planned and ‘protected’ procedures of PMVR with Impella CP mechanical circulatory support. No procedure-related complications occurred. At 6-month clinical follow-up evaluation, an improvement of symptoms and functional class (New York Heart Association) was reported. Discussion: In the two cases reported, PMVR with Impella CP assistance was feasible, safe and effective in the setting of severe mitral regurgitation associated with dilated and severe left ventricular dysfunction. Extending the concept of ‘complex high-risk and indicated patients/procedures’ (CHIP) from the environment of coronary intervention, a ‘protected’ approach could lead to improve technical feasibility and clinical outcome in structural interventions, as advocated for ‘protected-percutaneous coronary intervention’.

Verified
Journal Article
Open access
PDF file
DCDaniel Cesarini
Daniel Cesarini
IMIacopo Muraca
Iacopo Muraca
MBMartina Berteotti
Martina Berteotti
AGAnna Maria Gori
Anna Maria Gori
ASAndrea Sorrentino
Andrea Sorrentino
RVRenato Valenti
Renato Valenti
Ticagrelor is currently considered a first-line choice in dual antiplatelet therapy (DAPT) following revascularization of acute coronary syndrome (ACS). However, its use is correlated with an increased incidence of two side effects, dyspnea and bradyarrhythmias, whose molecular mechanisms have not yet been defined with certainty and, consequently, neither of the therapeutic decisions they imply. We report the case of a patient with acute myocardial infarction treated with ticagrelor and aspirin as oral antithrombotic therapy after primary percutaneous coronary intervention (PCI), manifesting in a significant bradyarrhythmic episode that required a switch of antiplatelet therapy. Starting from this case report, this article aims to gather the currently available evidence regarding the molecular mechanisms underlying these side effects and propose possible decision-making algorithms regarding their management in clinical practice.

Verified
Journal Article
Open access
PDF file
FSfernando Scudiero
fernando Scudiero
Angelo SilverioAngelo Silverio
Angelo Silverio
IMIacopo Muraca
Iacopo Muraca
Vincenzo RussoVincenzo Russo
Vincenzo Russo
Marco Di MaioMarco Di Maio
Marco Di Maio
GPGuido Parodi
Guido Parodi
The characteristics and clinical course of hospitalized patients with coronavirus disease 2019 (COVID-19) have been widely described, while long-term data are still poor. The aim of this study was to evaluate the long-term clinical outcome and its association with right ventricular (RV) dysfunction in hospitalized patients with COVID-19. This was a prospective multicenter study of consecutive COVID-19 patients hospitalized at seven Italian Hospitals from 28 February to 20 April 2020. The study population was divided into two groups according to echocardiographic evidence of RV dysfunction. The primary study outcome was 1-year mortality. The propensity score matching was performed to balance for potential baseline confounders. The study population consisted of 224 patients (mean age 69 ± 14, male sex 62%); RV dysfunction was diagnosed in 63 cases (28%). Patients with RV dysfunction were older (75 vs. 67 years, p < 0.001), had higher prevenance of coronary artery disease (27% vs. 11%, p = 0.003), and lower left ventricular ejection fraction (50% vs. 55%, p < 0.001). The rate of 1-year mortality (67% vs. 28%; p ≤ 0.001) was significantly higher in patients with RV dysfunction compared with patients without. After propensity score matching, patients with RV dysfunction showed a worse long-term survival (62% vs. 29%, p < 0.001). The multivariable Cox regression model showed an independent association of RV dysfunction with 1-year mortality. RV dysfunction is a relatively common finding in hospitalized COVID-19 patients, and it is independently associated with an increased risk of 1-year mortality.

27 December 2024 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Open access
FMfrancesca maria di muro
francesca maria di muro
MCMaria Federica Crociani
Maria Federica Crociani
GNGiulia Nardi
Giulia Nardi
NCNiccolo' Ciardetti
Niccolo' Ciardetti
LBLucrezia Biagiotti
Lucrezia Biagiotti
AMAlessio Mattesini
Alessio Mattesini
Background: Lipoprotein(a) [Lp(a)] is associated with increased cardiovascular risk, but its influence on plaque characteristics at optical coherence tomography (OCT) evaluation is not fully understood. Aims: This study seeks to explore the impact of Lp(a) levels on plaque morphology as assessed by OCT in a very high‐risk subset of patients. Methods: Consecutive patients admitted for acute coronary syndrome (ACS) and undergoing OCT‐guided percutaneous coronary intervention (PCI) at a large tertiary care center between 2019 and 2022 were deemed eligible for the current analysis. The overall population was categorized into two subgroups according to baseline Lp(a) levels: (1) lower Lp(a) (Lp(a) ≤ 300 mg/L) and (2) elevated Lp(a) (Lp(a) 300 mg/L). Predictors of lipid‐rich plaques were identified using multivariable logistic regression with stepwise selection of candidate covariates. Results: A total of 202 patients were included in this study. OCT findings revealed that patients with elevated Lp(a) had a higher prevalence of lipid‐rich plaques, a significantly greater mean lipid arc, along with increased macrophage infiltration and thin‐cap fibroatheroma (TCFA). In contrast, calcific plaque prevalence was higher in the lower Lp(a) group. Multivariable regression analysis identified low‐density lipoprotein cholesterol ≥ 70 mg/dL, and elevated Lp(a) as strong predictors of lipid‐rich plaques at OCT. Conclusion: In this observational study including ACS patients undergoing OCT‐guided PCI, those with elevated Lp(a) levels exhibited a higher prevalence of lipid‐rich plaques, increased macrophage infiltration, and TCFA, thereby indicating a more vulnerable plaque phenotype. Additionally, elevated Lp(a) levels and LDL‐C levels ≥ 70 mg/dL were each independently associated with lipid enrichment of coronary plaques. These findings suggest Lp(a), beyond other well‐known risk factors, as a key marker for risk stratification, potentially informing optimal medical management strategies.

2 August 2024 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
EMEnrico Marchi
Enrico Marchi
IMIacopo Muraca
Iacopo Muraca
DCDaniel Cesarini
Daniel Cesarini
MPMatteo Pennesi
Matteo Pennesi
RVRenato Valenti
Renato Valenti
Background: ST elevation myocardial infarctions are usually a consequence of the occlusion of a single coronary artery, but in 2.5% of the cases, two or more culprit lesions are found. Simultaneous coronary artery occlusion is a potentially life-threatening condition that leads to cardiogenic shock or ventricular arrhythmias. Case summary: We presented the case of a 74-year-old man presenting with chest pain and ST segment elevation (STE) in inferior leads and evidence of alternating STE in anterior leads in a pattern like Wellens syndrome type A in subsequent electrocardiogram (ECGs). Emergency coronary angiography (CA) revealed thrombotic occlusion of the proximal right coronary artery (RCA) and sub-occlusion of mid left anterior descending artery (LAD). During the CA, he became haemodynamically unstable requiring intravenous inotropes and vasopressors, and he underwent primary percutaneous coronary intervention of both RCA and LAD culprit lesions. His subsequent hospital stay was uneventful, and he was discharged 5 days later. Discussion: ST elevation myocardial infarction with more than one culprit coronary artery is a rare but at high risk of haemodynamic decompensation. The causes of occlusion of multiple coronary arteries may be several: coronary embolism, coronary ectasia, simultaneous plaque disruption, coronary vasospasm, hypercoagulability states, smoking, and illicit drug abuse. The presumed mechanism behind the presented case may be a combination of release of pro-thrombotic cytokines due to the thrombotic occlusion of the first coronary and low output state secondary to myocardial dysfunction leading to impaired flow in a severe stenotic coronary artery with subsequent thrombosis.

12 April 2022 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
PDF file
FSfernando Scudiero
fernando Scudiero
IMIacopo Muraca
Iacopo Muraca
AMAngela Migliorini
Angela Migliorini
RMRosella Marcucci
Rosella Marcucci
MPMatteo Pennesi
Matteo Pennesi
RVRenato Valenti
Renato Valenti
Background. This study is aimed at comparing the clinical outcomes of unprotected left main coronary artery disease (ULMCAD) treatment with contemporary percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in a “real-world” population. Methods and Results. Overall, 558 consecutive patients with ULMCAD (mean age 71 ± 9 years, male gender 81%) undergoing PCI or CABG were compared. The primary endpoint was the composite of death, nonfatal myocardial infarction, or stroke. Diabetes was present in 29% and acute coronary syndrome in 56%; mean EuroSCORE was 11 ± 8. High coronary complexity (SYNTAX score >32) was present in 50% of patients. The primary composite endpoint was similar after PCI and CABG up to 4 years (15.5 ± 3.1% vs. 17.1 ± 2.6%; p = 0.585 ). The primary end point was also comparable in a two propensity score matched cohorts. Ischemia-driven revascularization was more frequently needed in PCI than in CABG (5.5% vs. 1.5%; p = 0.010 ). By multivariate analysis, diabetes mellitus (HR 2.00; p = 0.003 ) and EuroSCORE (HR 3.71; p < 0.001 ) were the only independent predictors associated with long-term outcome. Conclusions. In a “real-world” population with ULMCAD, a contemporary revascularization strategy by PCI or CABG showed similar long-term clinical outcome regardless of the coronary complexity.